macromomycin-protein and Leukemia-P388

macromomycin-protein has been researched along with Leukemia-P388* in 1 studies

Other Studies

1 other study(ies) available for macromomycin-protein and Leukemia-P388

Article	Year
[Antitumor activity of macromomycin]. Gan to kagaku ryoho. Cancer & chemotherapy, 1982, Volume: 9, Issue:6 An antitumor activity of macromomycin, a polypeptide antitumor antibiotic, was tested in vitro and in vivo. The results obtained were as follows: 1) The cytostatic effect on L1210 cells in culture was identical to that of neocarzinostatin. 2) The effect of MCR on the survival of L1210 or P388 leukemia was as same level as NCS. 3) Effects of MCR were independent from the treatment schedules. 4) MCR was inactive on the survival of Lewis lung carcinoma. Topics: Animals; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Drug Administration Schedule; Leukemia L1210; Leukemia P388; Lung Neoplasms; Mice; Neoplasms, Experimental; Peptides	1982

Article

Year

Gan to kagaku ryoho. Cancer & chemotherapy, 1982, Volume: 9, Issue:6

An antitumor activity of macromomycin, a polypeptide antitumor antibiotic, was tested in vitro and in vivo. The results obtained were as follows: 1) The cytostatic effect on L1210 cells in culture was identical to that of neocarzinostatin. 2) The effect of MCR on the survival of L1210 or P388 leukemia was as same level as NCS. 3) Effects of MCR were independent from the treatment schedules. 4) MCR was inactive on the survival of Lewis lung carcinoma.

Topics: Animals; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Drug Administration Schedule; Leukemia L1210; Leukemia P388; Lung Neoplasms; Mice; Neoplasms, Experimental; Peptides

1982